SUBSCRIBE
SUBSCRIBE

Australia

Genetown
8 New Ways Scientists Can Get Their CV At The Top Of A Search
June 20, 2017
 · 
1 min read
Let's Get Rid Of Clinical Trials
Biotech Beach
BioPharm Executive: Let’s Get Rid of Clinical Trials
June 20, 2017
 · 
4 min read
Ask these impressive final round interview questio
Biotech Bay
Life Sciences Professionals Name Top 30 Ideal Employers
What do life sciences professionals value in an employer? According to the first annual 2017 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity to do interesting and meaningful work, a competitive salary and a good reputation.
June 15, 2017
 · 
2 min read
 · 
Jennifer Fink
15 In-Demand Life Science Jobs in Northern California
Biotech Bay
15 In-Demand Life Science Jobs in Northern California
June 13, 2017
 · 
7 min read
Genetown
3 Job Interview Mistakes You Think You Avoided But Actually Didn’t
June 6, 2017
 · 
1 min read
Genetown
Top 3 Most Desirable Skills In The ‘New Breed’ Of Pharma Sales Rep
June 6, 2017
 · 
1 min read
Genetown
5 Easy(ish) Steps To Building A Biopharma Career
June 6, 2017
 · 
1 min read
Lone Star Bio
5 Strategies For Getting Hired Into Life Science Positions
June 6, 2017
 · 
1 min read
Genetown
The Tiny Yet Powerful Cover Letter
June 6, 2017
 · 
1 min read
Biotech Beach
16 Pharmaceuticals Interview Questions Applicants Should Ask During the Job Interview
Here are the top pharmaceuticals interview questions for you. They can help you clear any interview with ease. So let’s take a look at the questions now.
June 2, 2017
 · 
6 min read
Load More
PRESS RELEASES
Policy
Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Trial Use
September 21, 2023
 · 
2 min read
Business
The University of Queensland and Oxford Nanopore Technologies Team up to Accelerate Research Into Quality Control Testing for mRNA Vaccines
September 21, 2023
 · 
2 min read
Genetown
Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD
September 14, 2023
 · 
5 min read
BioMidwest
Avasa raises $1.55M in oversubscribed funding round with innovative implantable devices
September 13, 2023
 · 
2 min read
Recce Pharmaceuticals Secures $8M Placement and Launches $3M Entitlement Offer to Shareholders
September 13, 2023
 · 
7 min read
Immuron achieves record monthly Travelan® sales
September 13, 2023
 · 
3 min read
BioMidwest
Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023
September 12, 2023
 · 
2 min read
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
September 12, 2023
 · 
3 min read
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry PartnerTrial to Assess Multi Cancer Genetic Risk Assessment in General Practice
September 11, 2023
 · 
4 min read
New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance
September 11, 2023
 · 
5 min read
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright - September 11, 2023
September 11, 2023
 · 
1 min read
Recce Pharmaceuticals Announces RECCE® Trademark Registered in Vietnam, Strengthening Global IP Portfolio
September 7, 2023
 · 
3 min read
Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 7, 2023
 · 
2 min read
BioForest
SeptiCyte® RAPID Receives ICD-10-PCS Code from the U.S. Centers for Medicare & Medicaid Services (CMS)
September 6, 2023
 · 
3 min read
Immutep to Participate in September 2023 Investor Conferences
September 5, 2023
 · 
1 min read
Drug Development
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
September 5, 2023
 · 
4 min read
Recce Pharmaceuticals Provides Additional Positive Update on Patients Treated Under “Special Access Scheme”
September 1, 2023
 · 
7 min read
Biotech Bay
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
August 31, 2023
 · 
8 min read
Annual Results – Momentum Building on our Commercial Plans
August 30, 2023
 · 
7 min read
Drug Development
Recce Pharmaceuticals Announces Safety Committee Approves Next Dose of RECCE® 327 at 3,000mg in Phase I/II UTI/Urosepsis Rapid Infusion Clinical Trial
August 29, 2023
 · 
3 min read
Load More